In situ demonstration of renal-cell-carcinoma-specific T-cell clones

International Journal of Cancer

Volumn 66, Issue 4, 1996, Pages 564-570

  Caignard, Anne ^a,b   Guillard, Maryvonne ^a   Gaudin, Catherine ^a   Escudier, Bernard ^b   Triebel, Frédéric ^a   Dietrich, Pierre Yves ^b,c  

^a INSERM   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c Hôpital universitaire   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ARTICLE; CELL CLONE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL DESTRUCTION;

BASE SEQUENCE; CARCINOMA, RENAL CELL; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; DNA PRIMERS; HUMANS; KIDNEY NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES;

EID: 0029950983     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960516)66:4<564::AID-IJC23>3.0.CO;2-6     Document Type: Article

References (20)

1. ALEXANDER, J., KUDOH, S., MELSOP, K., HAMILTON, T., EDINGER, M., TUBBS, R.R., SICA, D., TUASON, L., KLEIN, E., BUKOWSKI, R. and FINKE, J., T cells infiltrating renal-cell carcinoma display a poor proliferative response even though they can produce Interleukin 2 and express Interleukin-2 receptors. Cancer Res., 53, 1380-1387 (1993).
2. BALCH, C., RILEY, L.B., BAE, Y.J., SALMERON, M.A., PLATSOUCAS, C.D., VON ESCHENBACH, A. and ITOH, K., Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch. Surg., 125, 200-205 (1990).
3. + clone with unique anti-tumor specificity isolated from renal-cell-carcinoma ascitic fluid. Cancer Immunol. Immunother., 31, 1-10 (1990).
4. COULIE, P.G., SOMMEVILLE, M., LEHMAN, L., HAINAUT, P., BRASSEUR, F., DEVOS, R. and BOON, T., Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells. Int. J. Cancer, 50, 289-297 (1992).
5. FARACE, F., PALLARDY, M., ANGEVIN, E., HERCEND, T., ESCUDIER, B. and TRIEBEL, F., Metastatic-renal-cell-carcinoma patients treated with interleukin 2 or interleukin 2 plus interferon γ: immunological monitoring. Int. J. Cancer, 57, 814-821 (1994).
6. + T-cell line. J. Immunother., 11, 1-11 (1992).
7. FINKE, J.H., RAVMAN, P., HART, L., ALEXANDER, J.P., EDINGER, M.G., TUBBS, R.R., KLEIN, E., TUASON, L. and BUKOWSKI, R., Characterization of tumor-infiltrating lymphocyte sub-sets from human renal-cell carcinoma: specific reactivity defined by cytotoxicity, interferon-γ secretion and proliferation. J. Immunother., 15, 91-104 (1994).
8. Ick in T-cell-infiltrating human renal-cell carcinoma. Cancer Res., 53, 5613-5616 (1993).
9. GAUDIN, C., DIETRICH, P.Y., ROBACHE, S., GUILLARD, M., ESCUDIER, B., TERRIER-LACOMBE, M.J., KUMAR, A., TRIEBEL, F. and CAIGNARD, A., In vivo local expansion of clonal T-cell sub-populations in renal-cell carcinoma. Cancer Res., 55, 685-690 (1995).
10. GENÉVÉE, C., DIU, A., NIERAT, J., CAIGNARD, A., DIETRICH, P.Y., FERRADINI, L., ROMAN-ROMAN, S., TRIEBEL, F. and HERCEND, T., An experimentally validated panel of sub-family-specific oligonucleotide primers (Valphal-w29/Vbetal-w24) for the study of human T-cell-receptor variable V gene segment usage by polymerase chain reaction. Europ. J. Immunol., 22, 1261-1269 (1992).
11. GHOSH, P., SICA, A., YOUNG, H.A., YE, J., FRANC, J.L., WILTROUT, R.H., LONGO, D.L., RICE, N.R. and KOMSCHLIES, K.L., Alterations in NFkB/Rel family proteins in splenic T cells from tumor-bearing mice and reversal following therapy. Cancer Res., 54, 2969-2972 (1994).
12. LI, X., LIU, J., PARK, J.K., HAMILTON, T., RAVMAN, P., KLEIN, E., EDINGER, M., TUBBS, R., BUKOWSKI, R. and FINKE, J., T cells from renal-cell carcinoma patients exhibit an abnormal pattern of kB-specific DNA-binding activity: a preliminary report. Cancer Res., 54, 5424-5429 (1994).
13. MACKENSEN, A., GARCELIN, G., VIEL, S., RAYNAL, M.C., MICHALAKI, H., TRIEBEL, F., BOSQ, J. and HERCEND, T., Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J. clin. Invest., 93, 1397-1402 (1994).
14. MIZOGUCHI, H., O'SHEA, J.J., LONGO, D.L., LOEFFLER, C.M., MCVICAR, D.W. and OCHOA, A.C., Alterations in signal-transduction molecules in T lymphocytes from tumor-bearing mice. Science, 258, 1795-1798 (1992).
15. PANNETIER, C., EVEN, J. and KOURILSKY, P., T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol. Today, 16, 176-181 (1995).
16. PARDOLL, D.M., A new look for the 1990's. Nature (Lond.), 369, 357-359 (1994).
17. SCHENDEL, D.J., GANSBACHER, B., OBERNEDER, R., KRIEGMAIR, M., HOFSTETTER, A., REITHMULLER, G. and SEGURADO, O.G., Tumor-specific lysis of human renal-cell carcinomas by tumor-infiltrating lymphocytes. J. Immunol., 151, 4209-4220 (1993).
18. + T-cell clones isolated from human renal-cell carcinoma possess the functional characteristics of Th2 helper cells. Cell. Immunol., 150, 114-123 (1993).
19. SENSI, M. and PARMIANI, G., Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses. Immunol. Today, 16, 588-595 (1995).
20. WEIDMAN, E., ELDER, E., TRUCCO, M., LOTZE, M. and WHITESIDE, T., Usage of T-cell-receptor Vb chain genes in fresh and cultured tumor-infiltrating lymphocytes from human melanoma. Int. J. Cancer, 54, 383-390 (1993).